Your browser doesn't support javascript.
loading
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.
Papp, K; Thaçi, D; Reich, K; Riedl, E; Langley, R G; Krueger, J G; Gottlieb, A B; Nakagawa, H; Bowman, E P; Mehta, A; Li, Q; Zhou, Y; Shames, R.
Afiliación
  • Papp K; Probity Medical Research, 135 Union Street East, Waterloo, ON, N2J 1C4, Canada.
  • Thaçi D; Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany.
  • Reich K; SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany.
  • Riedl E; Division of General Dermatology, Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Langley RG; Dalhousie University, Halifax, NS, Canada.
  • Krueger JG; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, U.S.A.
  • Gottlieb AB; Department of Dermatology, Tufts Medical Center, Boston, MA, U.S.A.
  • Nakagawa H; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
  • Bowman EP; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
  • Mehta A; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
  • Li Q; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
  • Zhou Y; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
  • Shames R; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
Br J Dermatol ; 173(4): 930-9, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26042589
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2015 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2015 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido